Search

Reading Time: 3 minutes Executives in the sector discuss the future of biotech in a post-pandemic world. Stevenage Bioscience Catalyst (SBC) is a leading location for companies to develop and commercialize cutting-edge therapeutics. The Stevenage Campus is home to more than 40 organizations, including a growing number of start-ups, and employs over 3,500 people. Located within the golden triangle […]

Article

Reading Time: 2 minutesIn honor of Lung Cancer Awareness Month, this blog is authored by Dave Bjork, a Medidata Patient Insights Board member who faced lung cancer. Every year when November comes, I express how grateful I am to have had a positive outcome from my lung cancer diagnosis. It’s Lung Cancer Awareness Month and I’m here to […]

Article

Reading Time: 5 minutesThis is the fourth blog in the 5 Ways CROs Can Future Proof Their Medical Imaging Strategy series. This blog was authored by Andrea Falkoff, Senior Director, Product Management, Rave Imaging at Medidata. Andrea is responsible for the Medidata Rave Imaging product strategy and also works directly with customers and internal stakeholders to ensure best […]

Article

Reading Time: 3 minutesAccess to compelling and relevant evidence is crucial to drug development, safety monitoring, and improved patient outcomes. But silos between clinical trial data (CTD) and real-world data (RWD) make it difficult to fully understand what happens to patients outside of a clinical trial. Historically, the disconnect between CTD and RWD stems from patient privacy concerns. […]

Article

Reading Time: 4 minutesToday’s clinical trial data from remote patient care, imaging, wearables, labs, and other sources has grown exponentially, leaving traditional clinical data management processes lagging in the ability to efficiently scale. Trial data is often managed with data management tools and processes that are not interoperable and simply have not been able to adapt at the […]

Article

Reading Time: 4 minutes This is the fifth blog in the 5 Ways CROs Can Future Proof Their Medical Imaging Strategy series. Summary We began this blog series by talking about the growing importance and prevalence of medical images in clinical trials—especially in oncology and early-phase trials. We discussed how to develop a medical imaging strategy by evaluating current […]

Article

Reading Time: 2 minutesMedidata Link, the world’s first comprehensive data-linkage solution, has been awarded the prestigious 2022 Innovations in Regulatory Science Award from the Reagan-Udall Foundation for the FDA—also known as the FDA Foundation. The Innovation Award recognizes individuals or organizations that have made particularly groundbreaking contributions to regulatory science or policy to improve public health. The FDA […]

Article

Reading Time: 2 minutes Chimeric antigen receptor (CAR) T-cell therapy is an incredibly promising immunotherapy for several hematological cancers, especially for patients who have exhausted other treatment options. CAR T works by altering a patient’s own blood to produce artificial, genetically engineered T cell receptors that recognize and eliminate cancerous cells in the body.[1] The most common form of […]

Article

Reading Time: 4 minutesClinical data is growing more rapidly than ever before. More clinical trial data sources, devices, and data points have led to greater complexity and pronounced changes across the world of clinical data management. And this means that yesterday’s processes and best practices no longer scale in today’s data management landscape. The solution? A next-generation clinical […]

Article

Reading Time: 3 minutes Clinical trials continue to increase in complexity. They rely on an expanding array of high-volume and high-velocity data from various sources and increasingly rely upon decentralized and adaptive designs. Consequently, the paradigm for clinical trial monitoring has permanently changed. It has shifted towards remote and risk-based approaches to monitor patient safety and data quality proactively […]

Article

Reading Time: 2 minutesData linkage—the process of connecting clinical trial data (CTD) and real-world data (RWD) to show a comprehensive view of the patient journey—is shifting the existing paradigm of clinical trials. Whereas CTD and RWD have traditionally existed in silos, a robust data linkage solution can help sponsors overcome these gaps that hinder evidence generation. With a […]

Article

Reading Time: 5 minutes Decentralized clinical trials (DCTs) have the potential to enhance the patient trial experience, recruit more diverse clinical trial patients no matter where they live, offer greater flexibility, and provide cost efficiencies—all with the goal of delivering safe and effective treatments to market faster. To capitalize on the many benefits of DCTs, sponsors must focus on […]

Article